Saving the Underserved in Egypt and India… We at The Eye Cancer Foundation are pleased to celebrate the graduation of our two most recent recent fellows: Dr. Puneet Jain from India and Dr. Moanes Morkos from Egypt. In traditional ECF manner, both fellows return to their country with goals to care for eye cancer patients, [..] Read More…
New Radiation Instructions for Eye Plaque Patients 2018 Based on published guidelines from United States Nuclear Regulatory Commission (NRC), The New York Eye Cancer Center and its affiliate New York Eye and Ear Infirmary of Mt. Sinai have agreed that patients undergoing low energy (iodine-125 or palladium-103) eye plaque radiation therapy for intraocular melanoma are [..] Read More…
November 22nd Cairo, Egypt: November 22nd Cairo, Egypt: Physician scholars came together for The 2nd Middle East Ophthalmic Oncology & Pediatric Retina Meeting. Organized by Dr. Ihab Othman, the meeting fostered discussion of various topics in ocular oncology. The Eye Cancer Foundation (ECF) fellow, Dr. Abhilasha Maheshwari, shared recent findings of ECF supported research. She [..] Read More…
Byline: Published in The American Journal of Ophthalmology, 2019;198:45-53 Since 1940, a single, thin layer of amniotic membrane graft (AMG) has often been used for repairing the cornea and conjunctiva. However, Dr. Finger says: “our research shows that super-thick AMG (ST-AMG), up to ten times thicker than the prior AMG, is more effective for [..] Read More…
What is a myxoma? With a minuscule incidence of less than 0.005%, a myxoma is a staggeringly rare condition. Defined as noncancerous tumors of our connective tissue, myxomas present similarly to other, slightly more common conditions such as conjunctival lymphoma, lymphangioma, ocular surface squamous neoplasia (OSSN), or amelanotic melanoma. Consequently, they are usually misdiagnosed, or, [..] Read More…
Miraculous medicinal herbs may no longer be considered alternative medicine. A natural plant derivative has recently shown promise as the basis of a lasting cure for malignant tumor growth, particularly in the progression of ocular melanoma. Ocular melanoma progresses when certain proteins in the cells of our body become locked in an active state, overwhelming [..] Read More…
October 2018–––In a recent publication in Cornea: The Journal of Cornea and External Disease, a noteworthy case report describes a patient with squamous cell carcinoma (SCC) in his only functioning eye who had his vision saved using a remarkable application of palladium-103 plaque radiation therapy. Of all subtypes of conjunctival and corneal cancer, SCC [..] Read More…
The Fall 2018 issue of The Visionary is now available! The Eye Cancer Foundation publishes The Visionary free-of-charge to keep you informed about the latest news, research, and global efforts focused on improving eye cancer treatment, diagnosis, and cure. In this edition, you will find articles about: Progress on the 20/20 Campaign, run by the [..] Read More…
Patients who have had treatment for a choroidal melanoma with radiation plaque brachytherapy will sometimes go on to develop retinal problems secondary to the radiation exposure which was needed to sterilize their tumor. This is called radiation retinopathy. These retinal problems can manifest as an increased thickness of the retina and/or intraretinal and subretinal fluid [..] Read More…
Retinoblastoma (RB) is the most common eye cancer in children, affecting approximately 8,000 of them each year. In developed countries like the United States, the survival rate reaches beyond an astounding 96%, with early diagnosis and treatment being key to saving a patient’s life and sight. However, this incidence rate is higher in developing countries, [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
